Cubist Pharmaceuticals ranked 31st on FORTUNE's 2010' 100 Fastest-Growing Companies' list

NewsGuard 100/100 Score
Aug 21 2010

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it has been ranked 31st on FORTUNE's 2010 "100 Fastest-Growing Companies" list and the top pharmaceutical company. In the "Profit Growth" subgroup Cubist ranked 21st. The magazine will be on the newsstands on August 23 and the full list is available today online.

Michael W. Bonney, Cubist's president and CEO, said: "We are honored to be included among some of the top performing companies in the world in the FORTUNE list of the '100 Fastest Growing Companies.' Our employees share the credit for making that possible. They are the ones who commit daily to our mission of defeating some of the most confounding drug-resistant bacteria known to man. Together we are making progress as is evident in our exciting and important pipeline programs."

Source:

Cubist Pharmaceuticals, Inc.

Posted in:

Tags: , , , ,

Comments (0)

Suggested Reading

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms
Lancet Commission predicts sharp increase in global prostate cancer cases
Georgetown study raises concerns over aspirin's role in breast cancer treatment
New urine-based test improves identification of high-grade prostate cancer
Lab to plant: Scaling up API processes with Dr. James Mencel's guidance
Study highlights global fertility decline and its implications for the future
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
Extended CPAP treatment boosts lung development in premature infants

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Study highlights growing burden of neurological disorders worldwide